Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Immunity. 2010 Oct 29;33(4):464-78. doi: 10.1016/j.immuni.2010.10.007.

Designing vaccines based on biology of human dendritic cell subsets.

Author information

  • 1Baylor Institute for Immunology Research, 3434 Live Oak Avenue, Dallas, TX 75204, USA. karolinp@baylorhealth.edu

Abstract

The effective vaccines developed against a variety of infectious agents, including polio, measles, and hepatitis B, represent major achievements in medicine. These vaccines, usually composed of microbial antigens, are often associated with an adjuvant that activates dendritic cells (DCs). Many infectious diseases are still in need of an effective vaccine including HIV, malaria, hepatitis C, and tuberculosis. In some cases, the induction of cellular rather than humoral responses may be more important because the goal is to control and eliminate the existing infection rather than to prevent it. Our increased understanding of the mechanisms of antigen presentation, particularly with the description of DC subsets with distinct functions, as well as their plasticity in responding to extrinsic signals, represent opportunities to develop novel vaccines. In addition, we foresee that this increased knowledge will permit us to design vaccines that will reprogram the immune system to intervene therapeutically in cancer, allergy, and autoimmunity.

Copyright © 2010 Elsevier Inc. All rights reserved.

PMID:
21029958
[PubMed - indexed for MEDLINE]
PMCID:
PMC2975953
Free PMC Article

Images from this publication.See all images (5)Free text

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Publication Types, MeSH Terms, Substances, Grant Support

Publication Types

MeSH Terms

Substances

Grant Support

PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for PubMed Central
    Loading ...
    Write to the Help Desk